Ilios Therapeutics

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://www.iliostx.com/

Last Round

Seed

Sep 5, 2023

Company Overview

Ilios Therapeutics is a biotechnology company that develops multi-functional, brain-penetrant small molecules to treat neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small molecule therapeuticsdrug discoverybiotechneurodegenerative diseaseneurodegenerationbiotech startupdrug discovery platformmedicinal chemistryAI-driven drug discoverydrug designneuroscience researchpreclinical researchdrug pipelineAI in pharmaALS research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ilios Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Ilios Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ilios Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 5, 2023
Accelerator	Jul 11, 2022
Pre Seed	Apr 1, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Luca Giani

Co-Founder And CEO

Founding Team

Ilios Therapeutics Investors

Notable investors and investment history

Ilios Therapeutics investors
Investor	Rounds
Harvard Innovation Launch Lab	Pre Seed
Harvard Innovation Labs	Pre Seed
Club degli Investitori	Seed
Catalisi	Seed
MassChallenge	Accelerator, Pre Seed
InnoSpark Ventures	Seed
Exor Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 5, 2023
Seed round raised with participation from Exor Ventures and 3LB Seed Capital.

View all signals

Ilios Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ilios Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ilios Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Employee Range9

Year Founded2022

Last FundingSep 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.